← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2011Last known activity
Dec 16, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 4 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (7)
- NCT06223919CollaboratorPhase 3Dec 16, 2023
- NCT05366868Reponsible party - principal investigatorPhase 4May 26, 2022
- NCT05366868Lead sponsorPhase 4May 26, 2022
- NCT05366868Sponsor investigatorPhase 4May 26, 2022
- NCT03620474CollaboratorPhase 1/Phase 2Jul 24, 2018
- NCT01294761Overall official - principal investigatorN/AFeb 1, 2011
- NCT01294761Lead sponsorN/AFeb 1, 2011
Details
- Last known activity
- Dec 16, 2023